CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34
The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry
Jiro Aoki, MD*,
Patrick W. Serruys, MD, PhD, FACC*,*,
Heleen van Beusekom, MD, PhD*,
Andrew T.L. Ong, MBBS, FRACP*,
Eugene P. McFadden, MBChB, MD, FRCPI, FACC*,
Georgios Sianos, MD, PhD*,
Willem J. van der Giessen, MD, PhD*,
Evelyn Regar, MD, PhD*,
Pim J. de Feyter, MD, PhD, FACC*,
H. Richard Davis, MSc ,
Stephen Rowland, PhD and
Michael J.B. Kutryk, MD, PhD
* Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands
OrbusNeich, Fort Lauderdale, Florida
Terrence Donnelly Heart Centre, St. Michael’s Hospital, University of Toronto, Toronto, Canada
Manuscript received December 9, 2004;
revised manuscript received January 22, 2005,
accepted January 25, 2005.
* Reprint requests and correspondence: Dr. Patrick W. Serruys, Thoraxcenter, Bd 406, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands (Email: p.w.j.c.serruys{at}erasmusmc.nl).
OBJECTIVES: This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process.
BACKGROUND: A "pro-healing" approach for prevention of post-stenting restenosis is theoretically favored over the use of cytotoxic or cytostatic local pharmacologic therapies. It is believed that the central role of the vascular endothelium is to maintain quiescence of the underlying media and adventitia.
METHODS: Sixteen patients with de novo coronary artery disease were successfully treated with implantation of endothelial progenitor cell (EPC) capture stents.
RESULTS: Complete procedural and angiographic success was achieved in all 16 patients. The nine-month composite major adverse cardiac and cerebrovascular events (MACCE) rate was 6.3% as a result of a symptom-driven target vessel revascularization in a single patient. There were no other MACCE despite only one month of clopidogrel treatment. At six-month follow-up, mean angiographic late luminal loss was 0.63 ± 0.52 mm, and percent stent volume obstruction by intravascular ultrasound analysis was 27.2 ± 20.9%.
CONCLUSIONS: This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease. Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease.
|
Abbreviations and Acronyms
| | EPC = endothelial progenitor cell | | HAMA = human antimurine antibody | | HEALING-FIM = Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man | | IVUS = intravascular ultrasound | | MACCE = major adverse cardiac and cerebrovascular events | | MI = myocardial infarction | | SMC = smooth muscle cell | | TIMI = Thrombolysis In Myocardial Infarction |
|
This article has been cited by other articles:
|
|
|
|
 
M. K. Hagensen, M. K. Raarup, M. B. Mortensen, T. Thim, J. R. Nyengaard, E. Falk, and J. F. Bentzon
Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury
Cardiovasc Res,
February 1, 2012;
93(2):
223 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-H. Lim, W.-W. Seo, W. Choe, C.-K. Kang, J. Park, H.-J. Cho, S. Kyeong, J. Hur, H.-M. Yang, H.-J. Cho, et al.
Stent Coated With Antibody Against Vascular Endothelial-Cadherin Captures Endothelial Progenitor Cells, Accelerates Re-Endothelialization, and Reduces Neointimal Formation
Arterioscler Thromb Vasc Biol,
December 1, 2011;
31(12):
2798 - 2805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. R. A. Goldsmith and D. Smith
Coronary revascularisation with Genous stent helps reduce the waiting time for lung resection
Eur J Cardiothorac Surg,
November 1, 2011;
40(5):
1248 - 1249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D. I. Simon
Vascular Inflammation and Repair: Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis
J. Am. Coll. Cardiol. Intv.,
October 1, 2011;
4(10):
1057 - 1066.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wohrle, R. Birkemeyer, S. Markovic, T.-V. Nguyen, A. Sinha, T. Miljak, J. Spiess, W. Rottbauer, and H. Rittger
Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease
Heart,
August 15, 2011;
97(16):
1338 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Klomp, M. A. Beijk, C. Varma, J. J. Koolen, E. Teiger, G. Richardt, F. Bea, N. van Geloven, N. J. Verouden, Y. K. Chan, et al.
1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study-High Risk of Restenosis): A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents With Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
August 1, 2011;
4(8):
896 - 904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shim, A. Mehta, S. Y. Lim, G. Zhang, C. H. Lim, T. Chua, and P. Wong
G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?
Cardiovasc Res,
January 1, 2011;
89(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-H. Chen and R. Matyal
The Management of Antiplatelet Therapy in Patients With Coronary Stents Undergoing Noncardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia,
December 1, 2010;
14(4):
256 - 273.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. I. Lev, D. Leshem-Lev, A. Mager, H. Vaknin-Assa, N. Harel, Y. Zimra, T. Bental, G. Greenberg, D. Dvir, A. Solodky, et al.
Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis
Eur. Heart J.,
November 1, 2010;
31(21):
2625 - 2632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ladhoff, B. Fleischer, Y. Hara, H.-D. Volk, and M. Seifert
Immune privilege of endothelial cells differentiated from endothelial progenitor cells
Cardiovasc Res,
October 1, 2010;
88(1):
121 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg and P. W. Serruys
Coronary Stents: Looking Forward
J. Am. Coll. Cardiol.,
August 31, 2010;
56(10_Suppl_S):
S43 - S78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski, D. Wallace-Bradley, S. Parker, S. Rowland, G. Nakazawa, M. Vorpahl, et al.
Development of a Novel Prohealing Stent Designed to Deliver Sirolimus From a Biodegradable Abluminal Matrix
Circ Cardiovasc Interv,
June 1, 2010;
3(3):
257 - 266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. S. Kumar and N. M. Caplice
Clinical Potential of Adult Vascular Progenitor Cells
Arterioscler Thromb Vasc Biol,
June 1, 2010;
30(6):
1080 - 1087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, et al.
GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
Eur. Heart J.,
May 1, 2010;
31(9):
1055 - 1064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg, H. J. Duckers, and P. W. Serruys
Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
Eur. Heart J.,
May 1, 2010;
31(9):
1032 - 1035.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Ma, B. Hibbert, B. Dhaliwal, T. Seibert, Y. X. Chen, X. Zhao, and E. R. O'Brien
Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3{beta} inhibitor
Cardiovasc Res,
May 1, 2010;
86(2):
338 - 345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Padfield, D. E. Newby, and N. L. Mills
Understanding the Role of Endothelial Progenitor Cells in Percutaneous Coronary Intervention
J. Am. Coll. Cardiol.,
April 13, 2010;
55(15):
1553 - 1565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
CardioPulse Articles
Eur. Heart J.,
January 1, 2010;
31(1):
1 - 8.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nakazawa, J. F. Granada, C. L. Alviar, A. Tellez, G. L. Kaluza, M. Y. Guilhermier, S. Parker, S. M. Rowland, F. D. Kolodgie, M. B. Leon, et al.
Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent Endothelialization
J. Am. Coll. Cardiol. Intv.,
January 1, 2010;
3(1):
68 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hobson and N. Curzen
Chapter 22 Current status of oral antiplatelet therapies
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Vasa-Nicotera and T. Gershlick
Chapter 29 Stent thrombosis
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N L Mills, O Tura, G J Padfield, C Millar, N N Lang, D Stirling, C Ludlam, M L Turner, G R Barclay, and D E Newby
Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention
Heart,
December 15, 2009;
95(24):
2003 - 2008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, D. J. Kereiakes, N. S. Kleiman, D. J. Moliterno, G. Patti, and C. L. Grines
Combining Antiplatelet and Anticoagulant Therapies
J. Am. Coll. Cardiol.,
July 7, 2009;
54(2):
95 - 109.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Shedden, K. Oldroyd, and P. Connolly
Current issues in coronary stent technology
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine,
July 1, 2009;
223(5):
515 - 524.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Hibbert, X. Ma, A. Pourdjabbar, E. Holm, K. Rayner, Y.-X. Chen, J. Sun, L. Filion, and E. R. O'Brien
Inhibition of endothelial progenitor cell glycogen synthase kinase-3{beta} results in attenuated neointima formation and enhanced re-endothelialization after arterial injury
Cardiovasc Res,
July 1, 2009;
83(1):
16 - 23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Froehlich, R. Gulati, B. Boilson, T. Witt, A. Harbuzariu, L. Kleppe, A. B. Dietz, A. Lerman, and R. D. Simari
Carotid Repair Using Autologous Adipose-Derived Endothelial Cells
Stroke,
May 1, 2009;
40(5):
1886 - 1891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Stahli, G. G. Camici, and F. C. Tanner
Drug-eluting stent thrombosis
Therapeutic Advances in Cardiovascular Disease,
February 1, 2009;
3(1):
45 - 52.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. J. Schoen
Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering
Circulation,
October 28, 2008;
118(18):
1864 - 1880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation,
October 23, 2007;
116(17):
1952 - 1965.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Riddell, L. Chiche, B. Plaud, and M. Hamon
Coronary Stents and Noncardiac Surgery
Circulation,
October 16, 2007;
116(16):
e378 - e382.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Daemen and P. W. Serruys
Drug-Eluting Stent Update 2007: Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?
Circulation,
July 17, 2007;
116(3):
316 - 328.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, D. J. Kereiakes, W. K. Laskey, A. Colombo, S. G. Ellis, T. D. Henry, J. J. Popma, P. W.J.C. Serruys, T. Kimura, D. O. Williams, et al.
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. F. Luscher, J. Steffel, F. R. Eberli, M. Joner, G. Nakazawa, F. C. Tanner, and R. Virmani
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Circulation,
February 27, 2007;
115(8):
1051 - 1058.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Inoue, M. Sata, Y. Hikichi, R. Sohma, D. Fukuda, T. Uchida, M. Shimizu, H. Komoda, and K. Node
Mobilization of CD34-Positive Bone Marrow-Derived Cells After Coronary Stent Implantation: Impact on Restenosis
Circulation,
February 6, 2007;
115(5):
553 - 561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. T.L. Ong, J. Daemen, B. A. van Hout, P. A. Lemos, J. L. Bosch, R. T. van Domburg, and P. W. Serruys
Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry
Eur. Heart J.,
December 2, 2006;
27(24):
2996 - 3003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. V. Pislaru, A. Harbuzariu, R. Gulati, T. Witt, N. P. Sandhu, R. D. Simari, and G. S. Sandhu
Magnetically Targeted Endothelial Cell Localization in Stented Vessels
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1839 - 1845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wassmann, N. Werner, T. Czech, and G. Nickenig
Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells
Circ. Res.,
October 13, 2006;
99(8):
E74 - E83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Schmidt, L. M. Asmis, B. Odermatt, J. Kelm, C. Breymann, M. Gossi, M. Genoni, G. Zund, and S. P. Hoerstrup
Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors.
Ann. Thorac. Surg.,
October 1, 2006;
82(4):
1465 - 1471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tsimikas
Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited
J. Am. Coll. Cardiol.,
May 16, 2006;
47(10):
2112 - 2115.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Serruys
Fourth Annual American College of Cardiology International Lecture: A Journey in the Interventional Field
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1754 - 1768.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Blindt, F. Vogt, I. Astafieva, C. Fach, M. Hristov, N. Krott, B. Seitz, A. Kapurniotu, C. Kwok, M. Dewor, et al.
A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia by Recruiting Endothelial Progenitor Cells
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1786 - 1795.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1689 - 1706.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung
Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint
J. Am. Soc. Nephrol.,
April 1, 2006;
17(4):
1112 - 1127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Menasche
You Can't Judge a Book by Its Cover
Circulation,
March 14, 2006;
113(10):
1275 - 1277.
[Full Text]
[PDF]
|
|
|
|
